glp-1 endurance athletes Are GLP-1s Performance-Enhancing Drugs? glp 1 endurance athletes 💉

Magnesium is required for NMDA receptor function and synaptic plasticity

How do GLP-1 injections help you lose weight

A realistic timeline, based on where the Phase 3 programme is now, looks like this: FDA submission in the U.S.: late 2026 or 2027 FDA approval: 2027 or 2028 UK MHRA review: typically 12 to 24 months after FDA approval NHS access through a NICE appraisal: a separate process, usually 12 to 24 months after MHRA approval The earliest UK private access through online pharmacies, mirroring how Mounjaro and Wegovy first launched here, is likely 2027 or 2028

Nov 8: A new chapter opened Wednesday in the obesity treatment space as the FDA approved Eli Lillys Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or excessive weight with at least one weight-related condition, such as hypertension, type 2 diabetes (T2D) or high cholesterol

In the salt form of the same peptide sequence